Theodore Holman

Dr. Theodore Holman

Chemistry & Biochemistry Department, University of California at Santa Cruz, Santa Cruz, CA, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
KIKenneth N. Ikei
Kenneth N. Ikei
JYJennifer Yeung
Jennifer Yeung
PAPatrick L. Apopa
Patrick L. Apopa
JCJesús Ceja
Jesús Ceja
JVJoanne Vesci
Joanne Vesci
MHMichael Holinstat
Michael Holinstat
Human platelet-type 12-lipoxygenase (12-LOX) has recently been shown to play an important role in regulation of human platelet function by reacting with arachidonic acid (AA). However, a number of other fatty acids are present on the platelet surface that, when cleaved from the phospholipid, can be oxidized by 12-LOX. We sought to characterize the substrate specificity of 12-LOX against six essential fatty acids: AA, dihomo-γ-linolenic acid (DGLA), eicosapentaenoic acid (EPA), α-linolenic acid (ALA), eicosadienoic acid (EDA), and linoleic acid (LA). Three fatty acids were comparable substrates (AA, DGLA, and EPA), one was 5-fold slower (ALA), and two showed no reactivity with 12-LOX (EDA and LA). The bioactive lipid products resulting from 12-LOX oxidation of DGLA, 12-(S)-hydroperoxy-8Z,10E,14Z-eicosatrienoic acid [12(S)-HPETrE], and its reduced product, 12(S)-HETrE, resulted in significant attenuation of agonist-mediated platelet aggregation, granule secretion, αIIbβ3 activation, Rap1 activation, and clot retraction. Treatment with DGLA similarly inhibited PAR1-mediated platelet activation as well as platelet clot retraction. These observations are in surprising contrast to our recent work showing 12(S)-HETE is a prothrombotic bioactive lipid and support our hypothesis that the overall effect of 12-LOX oxidation of fatty acids in the platelet is dependent on the fatty acid substrates available at the platelet membrane.

6 January 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DLDiane K. Luci
Diane K. Luci
JJJ. Brian Jameson
J. Brian Jameson
AYAdam Yasgar
Adam Yasgar
GDGiovanni Diaz
Giovanni Diaz
NJNetra Joshi
Netra Joshi
DMDavid J. Maloney
David J. Maloney

24 September 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GRGanesha Rai
Ganesha Rai
VKVictor Kenyon
Victor Kenyon
AJAjit Jadhav
Ajit Jadhav
LSLena Schultz
Lena Schultz
MAMichelle Armstrong
Michelle Armstrong
DMDavid J. Maloney
David J. Maloney

17 January 2024 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
SSSviatlana Samovich
Sviatlana Samovich
KMKarolina Mikulska-Ruminska
Karolina Mikulska-Ruminska
HDHaider H. Dar
Haider H. Dar
YTYulia Y. Tyurina
Yulia Y. Tyurina
VTVladimir A. Tyurin
Vladimir A. Tyurin
HBHülya Bayir
Hülya Bayir

8 July 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
VKVictor Kenyon
Victor Kenyon
GRGanesha Rai
Ganesha Rai
AJAjit Jadhav
Ajit Jadhav
LSLena Schultz
Lena Schultz
MAMichelle Armstrong
Michelle Armstrong
Theodore HolmanTheodore Holman
Theodore Holman

1 July 2020 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
SPSteven C. Perry
Steven C. Perry
CKChakrapani Kalyanaraman
Chakrapani Kalyanaraman
BTBenjamin E. Tourdot
Benjamin E. Tourdot
WCWilliam S. Conrad
William S. Conrad
OAOluwayomi Akinkugbe
Oluwayomi Akinkugbe
Theodore HolmanTheodore Holman
Theodore Holman
Steven C Perry, Chakrapani Kalyanaraman, Benjamin E Tourdot, William S. Conrad, Oluwayomi Akinkugbe, John Cody Freedman, Michael Holinstat, Matthew P. Jacobson, Theodore R. Holman